You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PTH1-34

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Osteoporotic Fractures Trial in New York (Teriparatide Prefilled Syringe, Placebo)

Completed
Has Results
  • Osteoporotic Fractures
  • Teriparatide Prefilled Syringe
  • Placebo
  • New York, New York
    Hospital for Special Surgery
Jul 26, 2022

Stress Fracture Trial in Norwich (Teriparatide)

Completed
  • Stress Fracture
  • Norwich, Norfolk, United Kingdom
    Norfolk and Norwich University Hospitals Foundation Trust
Aug 5, 2021

Male Osteoporosis Trial in San Francisco (Teriparatide or human parathyroid hormone (PTH) 1-34, Cinacalcet, tablet)

Recruiting
  • Male Osteoporosis
  • Teriparatide or human parathyroid hormone (PTH) 1-34
  • +4 more
  • San Francisco, California
    San Francisco VA Medical Center, San Francisco, CA
Dec 8, 2021

Healthy Volunteers Trial in Melbourne (RT-102, Forteo)

Recruiting
  • Healthy Volunteers
  • Melbourne, Australia
    Nucleus Network
Feb 24, 2022

Hypoparathyroidism Trial in Jerusalem (EBP05, Forteo 20 mg, EBP11)

Recruiting
  • Hypoparathyroidism
  • Jerusalem, Israel
    Clinical Research Center Hadassah Ein Kerem Medical Center
Jul 27, 2023

Hypoparathyroidism, Hypocalcemia Trial run by the NICHD (Synthetic Human Parathyroid Hormone 1-34)

Completed
  • Hypoparathyroidism
  • Hypocalcemia
  • Synthetic Human Parathyroid Hormone 1-34
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

Hypoparathyroidism, Endocrine System Diseases, Parathyroid Diseases Trial in Worldwide (TransCon PTH, Placebo)

Active, not recruiting
  • Hypoparathyroidism
  • +2 more
  • TransCon PTH
  • Placebo
  • San Francisco, California
  • +20 more
Aug 5, 2022

Hypoparathyroidism, Endocrine System Diseases, Parathyroid Diseases Trial in Worldwide (TransCon PTH, Placebo for TransCon PTH)

Active, not recruiting
  • Hypoparathyroidism
  • +2 more
  • TransCon PTH
  • Placebo for TransCon PTH
  • Chicago, Illinois
  • +14 more
Mar 2, 2022

Hypoparathyroidism, DiGeorge Syndrome Trial run by the NIDCR (PTH 1-34)

Terminated
Has Results
  • Hypoparathyroidism
  • DiGeorge Syndrome
  • PTH 1-34
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 19, 2019

Secondary Hyperparathyroidism Trial (PLS240, Placebo, Open-Label Extension PLS240)

Not yet recruiting
  • Secondary Hyperparathyroidism
  • (no location specified)
Apr 17, 2023

Hypoparathyroidism Trial in Jerusalem (EB612 (EBP05), NATPARA/NATPAR)

Completed
  • Hypoparathyroidism
  • Jerusalem, Israel
    Clinical Research Center Hadassah Ein Kerem Medical Center
Mar 22, 2019

Sickle Cell Disease Trial in Paris (DREPAGLOBE drug product)

Active, not recruiting
  • Sickle Cell Disease
  • DREPAGLOBE drug product
  • Paris, France
    Department of Biotherapy, Necker-Enfants Malades Hospital
Sep 26, 2022

Healthy Volunteers (Diabetes, Type 2) Trial in Harrow (Semaglutide B, 1.34 mg/mL, Semaglutide D, 1.0 mg/mL)

Completed
  • Healthy Volunteers (Diabetes Mellitus, Type 2)
  • Semaglutide B, 1.34 mg/mL
  • Semaglutide D, 1.0 mg/mL
  • Harrow, Middlesex, United Kingdom
    Novo Nordisk Investigational Site
Jan 29, 2023

Mental Health Issue, Children, Adult Trial in San Diego (After-Action Review)

Active, not recruiting
  • Mental Health Issue
  • Children, Adult
  • After-Action Review
  • San Diego, California
    UC San Diego - IN STEP Children's Mental Health Research Center
Nov 16, 2022

Osteoarthritis, Knee Trial in United States (KA34, Placebo)

Completed
Has Results
  • Osteoarthritis, Knee
  • Walnut Creek, California
  • +3 more
Dec 22, 2022

Diabetes, Type 2, Healthy Participants Trial in Cypress (Semaglutide B, 1.34 mg/mL, Semaglutide B, 0.68 mg/mL)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Healthy Participants
  • Semaglutide B, 1.34 mg/mL
  • Semaglutide B, 0.68 mg/mL
  • Cypress, California
    Novo Nordisk Investigational Site
Jan 9, 2023

Autosomal Dominant Hypocalcemia OR Primary Hypoparathyroidism Related to Other Cause But Complicated by Hypercalciuria Under

Completed
  • Autosomal Dominant Hypocalcemia OR Primary Hypoparathyroidism Related to Other Cause But Complicated by Hypercalciuria Under Treatment
  • Paris, France
    AP-HP Hopital Europeen Georges Pompidou
Jun 23, 2021

Apheresis of Patients With Immunodeficiency

Recruiting
  • LAD-1
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    PCOS (Polycystic Ovary Syndrome), Semaglutide Trial in Peking (Metformin Hydrochloride 500 MG, Semaglutide, 1.34 mg/mL,

    Not yet recruiting
    • PCOS (Polycystic Ovary Syndrome)
    • Semaglutide
    • Metformin Hydrochloride 500 MG
    • +4 more
    • Peking, Beijing, China
      PekingUFH
    Jan 18, 2023

    Spinal Stenosis Trial in Kalmar, Linköping (Teriparatide)

    Completed
    • Spinal Stenosis
    • Kalmar, Sweden
    • +1 more
    Apr 16, 2019

    Metastatic Non-Small Cell Lung Carcinoma Trial in Seoul (Pembrolizumab Injection)

    Recruiting
    • Metastatic Non-Small Cell Lung Carcinoma
    • Pembrolizumab Injection
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Nov 6, 2022

    P47-Phox, Deficiency of Trial in London (Lentiviral vector transduced CD34+ cells)

    Not yet recruiting
    • P47-Phox, Deficiency of
    • Lentiviral vector transduced CD34+ cells
    • London, United Kingdom
      Great Ormond Street Hospital
    Aug 2, 2022

    Metastatic Castration-resistant Prostate Cancer Trial (ONCT-534)

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • (no location specified)
    Jun 15, 2023

    Sickle Cell Disease Trial in Saint Louis (Motixafortide, Natalizumab, Leukapheresis)

    Not yet recruiting
    • Sickle Cell Disease
    • Saint Louis, Missouri
      Washington University School of Medicine
    Nov 8, 2022

    Blood Pressure Monitor Clinical Test

    Completed
    • Blood Pressure
      • Tianjin, China
        The First Affiliated Hospital of Tianjin University of Tradition
      Jul 30, 2023